Health ❯Healthcare ❯Cancer Treatment

Immunotherapy

Cancer Treatment Cancer Research Medical Research Clinical Trials Cancer Cancer Biology Cell Biology Oncology Patient Care Oncology

EGFR Inhibitors Show Promise Against Immunotherapy-Resistant NF1-Mutant Melanoma

A NYU Langone Health study uncovered a reliance on EGFR signaling in NF1-mutant tumors prompting early-phase trials of cetuximab plus afatinib.

Phase 3 Trial Launches to Test Electric Field and Immunotherapy Combo in Glioblastoma

Atezolizumab-Enhanced Chemotherapy Halves Recurrence in Stage III dMMR Colon Cancer

STAT3 Degraders Poised for Clinical Trials to Combat Immunotherapy Resistance

Study Reveals Radiotherapy-Induced Protein Drives Tumor Metastasis

Teddi Mellencamp Nears Cancer-Free Status as Final Immunotherapy Sessions Approach

NHS England to Introduce Europe’s First Injectable Cancer Immunotherapy

FDA Reviews Pembrolizumab for Transformative Head and Neck Cancer Treatment

Blocking EPO Signaling Eliminates Immune-Resistant Liver Tumors in Mice

Experimental Vaccine Keeps Kidney Cancer Patients Cancer-Free for Three Years